Navigation Links
Research on stem cells wins first prize for Hebrew University researcher
Date:6/21/2010

on of human ES cells also brings up the challenge of their possible rejection. His analysis of the immunogenicity of human ES cells has shown that although undifferentiated human ES cells express extremely low levels of immunogenic (rejecting) molecules, this expression is up-regulated when they differentiate,. Thus, human ES cells will probably be a target for cell rejection, and ways to overcome this issue should be further explored, he says.

During the past ten years, the research coming out of this laboratory has been published in over 50 papers, with many of the articles on human ES cells appearing as a cover story in the various journals in which they were published.

SCT - Stem Cell Technologies Ltd. was founded late in 2004 in order to capitalize on the experience and ongoing research from the Hebrew University of Jerusalem and from the Technion-Israel Institute of Technology in Haifa in the field of human ES cells. SCT is owned in equal shares by Yissum, the research and development company of the Hebrew University of Jerusalem, and TRDF the Technion Research and Development Foundation.

The main goal of SCT is to direct human ES cells to differentiate into insulin-secreting pancreatic beta cells for transplantation into diabetic patients. type 1 diabetes is an autoimmune disease caused by destruction and loss of function of beta cells in the pancreas. As a result, insulin is not produced, and blood glucose levels are not regulated. The disease causes a large number of symptoms: blindness, kidney disease and nerve damage, which can lead to amputations and death.

The mainstay treatment for type 1 diabetes is insulin injections. Although the exogenous insulin therapy has dramatically reduced mortality from diabetes, patients often succumb to the long-term complications. Transplantation of functional pancreatic cells represents one of the most promising approaches towards curing diabetes. However, currently this approach i
'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research on stem cells wins first prize for Hebrew University researcher
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
(Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... who self-paid for their antiretroviral medications experienced interruptions in ... logistical disruptions. These treatment interruptions led to the ... These findings by a team led by researchers at ... UCSF are reported in the April 22, 2007 issue ...
... College of Medicine have discovered a new way to use ... enter cancer cells. , The research appears in the Jan. ... , All living cells defend themselves by walling off the ... around the cell's inner machinery and its DNA blueprints. ...
... Autophagy is a cellular process that enables cells to ... is initiated in tumor cells by chemotherapy and radiation, ... tumor cell death or helps tumor cells survive the ... model of B cell lymphomas, researchers from the University ...
Cached Biology News:Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2Buckyballs used as 'passkey' into cancer cells 2
(Date:3/2/2015)... 02, 2015 In the five years ... has experienced robust growth. The industry, which consists of ... energy resources and other goods, has grown on account ... As a result, IBISWorld forecasts that industry revenue will ... $946.8 million over the five-year period, including an anticipated ...
(Date:3/2/2015)... March 2, 2015 VLP Therapeutics, LLC. ... company focusing on the research and development of ... agents based upon a novel and proprietary vaccine ... Sciences Impact Grant Award from the Montgomery County ... by MCDED, is awarded to life sciences companies ...
(Date:3/2/2015)... , March 2, 2015 ... and healthy whole food nutrition products reveal technological ... lifestyle related disorders such as hyperglycemia, obesity, insulin ... concerns.  Nutraceutical and Biotech Companies in focus today ... Nature Foods Ltd. (NYSE: ANFI ), ...
(Date:3/2/2015)... SANTA BARBARA, Calif. , March 2, 2015 ... a biotechnology company developing therapies for autoimmune and ... Trademark Office (USPTO) has issued an important new ... immune system function through the targeting of CLIP. ... the targeted peptide technology underlying VG Life Sciences, ...
Breaking Biology Technology:Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 2Laboratory Testing Services in Canada Industry Market Research Report Now Available from IBISWorld 3VLP Therapeutics Wins the 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3
... ... overview of genome browsers enable researchers to quickly and effectively use these invaluable resources. ... Seattle, WA (PRWEB) April 26, ... updated tutorial suite on the Overview of Genome Browsers. , , , Ensembl is ...
... and ,S-HERTOGENBOSCH, The Netherlands , April 28, 2010 , ... technology for the generation of immune therapeutics, today,announced that it reached ... ,s-Hertogenbosch. Under the terms of the,agreement Pepscan will receive an undisclosed ... , , ...
... April 27, 2010 Immunovo,BV, a new biotechnology company looking to ... develop novel,therapeutics, secures seed funding from Dutch venture capital firms. , ... ,S-Hertogenbosch, ... new,biotechnology company developing a novel technology platform for the creation,of a new ...
Cached Biology Technology:New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 2New and Updated Online Tutorials for Ensembl Legacy and Overview of Genome Browsers 3Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 2Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio 3Immunovo BV- A New Biotechnology Company is Announced 2